Abstract
BackgroundEngaging patients (parents/families) in treatment decisions is increasingly recognised as important and beneficial. Yet where the evidence base for treatment options is limited, as with intermittent distance exotropia (X(T)), this presents a challenge for families and clinicians. The purpose of this study was to explore how decisions are made in the management and treatment of X(T) and what can be done to support decision-making for clinicians, parents and children.MethodsThis was a qualitative study using face to face interviews with consultant ophthalmologists and orthoptists, and parents of children with X(T). Interview data were analysed using the constant comparative method.ResultsThe drivers for clinicians in treatment decision-making for X(T) were the proportion of time the strabismus is manifest and parents’ views. For parents, decisions were influenced by: fear of bullying and, to a lesser degree, concerns around the impact of the strabismus on their child’s vision. Uncertainty around the effectiveness of treatment options caused difficulties for some clinicians when communicating with parents. Parental understanding of the nature of X(T) and rationale for treatment often differed from that of the clinicians, and this affected their involvement in decision-making. Though there were good examples of shared decision-making and parent and child engagement some parents said the process felt rushed and they felt excluded. Parents reported that clinicians provided sufficient information in consultations but they had difficulties in retaining verbal information to convey to other family members.ConclusionsOverall parents were happy with the care their child received but there is scope for better parent and (where appropriate) child engagement in decision-making. There was an expressed need for written information about X(T) to reinforce what was given verbally in consultations and to share with other family members. Access could be via the hospital website, along with videos or blogs from parents and children who have undergone the various management options. A method of assisting clinicians to explain the treatment options, together with the uncertainties, in a clear and concise way could be of particular benefit to orthoptists who have the most regular contact with parents and children, and are more likely to suggest conservative treatments such as occlusion and minus lenses.Electronic supplementary materialThe online version of this article (doi:10.1186/s12886-015-0087-y) contains supplementary material, which is available to authorized users.
Highlights
Engaging patients in treatment decisions is increasingly recognised as important and beneficial
Four months into data collection we found many children identified were not receiving any active treatment for their strabismus and were being observed over time– this was especially so for the under 4’s - and data saturation was reached for this group
In the other two sites this is determined by the orthoptists and depends upon the features of the strabismus or whether the parents ask to speak to the consultant
Summary
Engaging patients (parents/families) in treatment decisions is increasingly recognised as important and beneficial. Intermittent distance exotropia (X(T)) is a form of childhood squint (strabismus) with an estimated prevalence of 1 % in children under 11 years [1]. A current large scale randomised controlled trial of occlusion for the treatment of X(T) in the United States, due for completion in 2015, may answer this question, as a secondary objective is to determine the natural history of X(T) in patients aged 3 to 11 years [3]. The longer term risks to a young child with X(T) are amblyopia (decreased vision due to developmental anomaly resulting from the strabismus) or loss of binocular vision. For this reason a child’s vision and strabismus will be regularly monitored. Due to its intermittent nature it is not certain if stigma and bullying are an issue for the majority of children with X(T)
Published Version (
Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have